These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22420909)

  • 1. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
    Bez C; Perrottet N; Zingg T; Leung Ki EL; Demartines N; Pannatier A
    J Eval Clin Pract; 2013 Apr; 19(2):374-8. PubMed ID: 22420909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
    Redfern RE; Brown M; Karhoff KL; Middleton JL
    South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan.
    Alqudah MA; Al-Azzam S; Alzoubi K; Alkhatatbeh M; Rawashdeh N
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):597-602. PubMed ID: 27125772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study.
    Alsultan MS; Mayet AY; Malhani AA; Alshaikh MK
    Saudi J Gastroenterol; 2010; 16(4):275-9. PubMed ID: 20871193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
    Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
    South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-related mucosal bleeding in critically ill oncology patients.
    Bruno JJ; Canada TW; Wakefield CD; Nates JL
    J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The appropriateness of a proton pump inhibitor prescription.
    Moran N; Jones E; O'Toole A; Murray F
    Ir Med J; 2014; 107(10):326-7. PubMed ID: 25551900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
    Hussain S; Stefan M; Visintainer P; Rothberg M
    South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
    López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
    Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
    Hwang KO; Kolarov S; Cheng L; Griffith RA
    J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit: a retrospective study.
    Tan B; Norman R; Litton E; Heath C; Hawkins DJ; Krishnamurthy R; Sonawane R; Anstey MH
    Crit Care Resusc; 2016 Dec; 18(4):270-274. PubMed ID: 27903209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.
    Atkins R; Smith L
    Consult Pharm; 2013 Dec; 28(12):786-92. PubMed ID: 24322962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
    Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
    Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
    Craig DG; Thimappa R; Anand V; Sebastian S
    QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.